List of Patents

« Back

Treatment of Spinal Muscular Atrophy using moxifloxacin

Treatment of Spinal Muscular Atrophy using moxifloxacin

Treatment of Spinal Muscular Atrophy using moxifloxacin

Treatment of Spinal Muscular Atrophy using moxifloxacin

 

Universitat de València's researchers in collaboration with the INCLIVA Foundation have identified the use of a molecule as a new candidate drug for developing a new therapy for Spinal Muscular Atrophy (SMA), that increases significantly surviving motor neuron (SMN) protein levels in various cellular disease models.

INDUSTRIAL PROPERTY RIGHTS:

INTELLECTUAL PROPERTY RIGHTS
The technology is patent application protected

Quality of Life: Health Promotion and Efficient Health

CONTACT:

Contacto:

Sección de Innovación y Valorización

Servicio de Transferencia e Innovación

Universitat de València

Avda. Blasco Ibáñez, 13, nivel 2

46010, Valencia

Tel: 96 386 40 61

e-mail: patentes.otri@uv.es

Web: http://www.uv.es/serinves